These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 12680478)

  • 21. Severe form of type 2 reaction in patients of Hansen's disease after withdrawal of thalidomide: case reports.
    Rattan R; Shanker V; Tegta GR; Verma GK
    Indian J Lepr; 2009; 81(4):199-203. PubMed ID: 20704076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apremilast in chronic recalcitrant erythema nodosum leprosum: a report of two cases.
    Narang T; Kaushik A; Dogra S
    Br J Dermatol; 2020 Apr; 182(4):1034-1037. PubMed ID: 31218666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experiences with Thalidomide for Erythema Nodosum Leprosum– a retrospective study.
    Darlong J; Govindharaj P; Charles DE; Menzies A; Mani S
    Lepr Rev; 2016 Jun; 87(2):211-20. PubMed ID: 30212168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythema Nodosum Leprosum: Update and challenges on the treatment of a neglected condition.
    Costa PDSS; Fraga LR; Kowalski TW; Daxbacher ELR; Schuler-Faccini L; Vianna FSL
    Acta Trop; 2018 Jul; 183():134-141. PubMed ID: 29474830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case Report: Rapid Response to Low-Dose Thalidomide in a Case of Severe Steroid Recalcitrant Erythema Nodosum Leprosum.
    Savitha B; Sardana K; Kumari R; Khurana A; Sinha S; Sachdeva S
    Am J Trop Med Hyg; 2021 Oct; 106(1):51-53. PubMed ID: 34662871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind trial of the efficacy of pentoxifylline vs thalidomide for the treatment of type II reaction in leprosy.
    Sales AM; de Matos HJ; Nery JA; Duppre NC; Sampaio EP; Sarno EN
    Braz J Med Biol Res; 2007 Feb; 40(2):243-8. PubMed ID: 17273661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thalidomide used by patients with erythema nodosum leprosum].
    Valente Mdo S; Vieira JL
    Rev Soc Bras Med Trop; 2010; 43(2):201-4. PubMed ID: 20464154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thalidomide levels in patients with erythema nodosum leprosum.
    Vieira JL; Valente Mdo S
    Ther Drug Monit; 2009 Oct; 31(5):602-3. PubMed ID: 19704404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of erythema nodosum leprosum using thalidomide].
    Sheskin J
    Acta Leprol; 1983; 1(1):41-50. PubMed ID: 6401140
    [No Abstract]   [Full Text] [Related]  

  • 30. Deep vein thrombosis: a rare complication of thalidomide therapy in recurrent erythema nodosum leprosum.
    Sharma NL; Sharma V; Shanker V; Mahajan VK; Sarin S
    Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):483-5. PubMed ID: 15755204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of rhuIFN-gamma treatment in multibacillary leprosy patients.
    Sampaio EP; Malta AM; Sarno EN; Kaplan G
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):268-73. PubMed ID: 8862260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
    Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
    Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effective treatment of erythema nodosum leprosum with thalidomide is associated with immune stimulation.
    Haslett PA; Roche P; Butlin CR; Macdonald M; Shrestha N; Manandhar R; Lemaster J; Hawksworth R; Shah M; Lubinsky AS; Albert M; Worley J; Kaplan G
    J Infect Dis; 2005 Dec; 192(12):2045-53. PubMed ID: 16288366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A real-world study of low-dose thalidomide in severe erythema nodosum leprosum highlighting its mechanistic rationale in a resource-constrained target population.
    Bathula S; Sardana K; Mathachan SR; Khurana A; Ahuja A; Paliwal P
    Int J Dermatol; 2023 Jan; 62(1):48-55. PubMed ID: 35924464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chemotherapy-induced erythema nodosum leprosum: successful treatment with thalidomide].
    Petering H; Kiehl P; Vogelbruch M; Sticht-Groh V; Kapp A; Werfel T
    Hautarzt; 2001 Oct; 52(10 Pt 2):966-9. PubMed ID: 11715395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of azathioprine in preventing recurrences in a patient of recurrent erythema nodosum leprosum.
    Verma KK; Srivastava P; Minz A; Verma K
    Lepr Rev; 2006 Sep; 77(3):225-9. PubMed ID: 17172003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thalidomide in erythema nodosum leprosum.
    Jew LJ; Middleton RK
    DICP; 1990 May; 24(5):482-3. PubMed ID: 2188435
    [No Abstract]   [Full Text] [Related]  

  • 38. Severe refractory erythema nodosum leprosum successfully treated with the tumor necrosis factor inhibitor etanercept.
    Ramien ML; Wong A; Keystone JS
    Clin Infect Dis; 2011 Mar; 52(5):e133-5. PubMed ID: 21292656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thalidomide and steroid in the management of erythema nodosum leprosum.
    P K Mishra SR; Samal R; Behera B
    Indian J Pharmacol; 2022; 54(3):177-182. PubMed ID: 35848688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum.
    Villahermosa LG; Fajardo TT; Abalos RM; Balagon MV; Tan EV; Cellona RV; Palmer JP; Wittes J; Thomas SD; Kook KA; Walsh GP; Walsh DS
    Am J Trop Med Hyg; 2005 May; 72(5):518-26. PubMed ID: 15891124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.